Inception IBD Receives $14,100,000 Series A Financing Round

  • Feed Type
  • Date
    12/14/2015
  • Company Name
    Inception IBD
  • Mailing Address
    Undisclosed San Diego, CA 92130 USA
  • Company Description
    Inception IBD is focused on translating academic discoveries in the field of IBD into first-in-class small molecule drugs.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,100,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funds will be used to advance a portfolio of therapeutics targeting the underlying pathogenesis of inflammatory bowel disease (IBD).
  • M&A Terms
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Fonds de solidarite FTQ
  • Venture Investor
    Undisclosed